461

Compound name
Zanubrutinib
Alt Name
Brukinsa
BGB-3111
Compound Image
Zanubrutinib.png
SMILES
C=CC(=O)N1CCC(CC1)C2CCNC3=C(C(=NN23)C4=CC=C(C=C4)OC5=CC=CC=C5)C(=O)N
MW
471.50
Brutto
C27H29N5O3
InChI
InChI=1S/C27H29N5O3/c1-2-23(33)31-16-13-18(14-17-31)22-12-15-29-27-24(26(28)34)25(30-32(22)27)19-8-10-21(11-9-19)35-20-6-4-3-5-7-20/h2-11,18,22,29H,1,12-17H2,(H2,28,34)/t22-/m0/s1
InChI Key
RNOAOAWBMHREKO-QFIPXVFZSA-N
Approval Jurisdiction
2019 FDA
Approved for clinical use
Mantle Cell Lymphoma
CAS
1691249-45-2
PubChem CID
135565884
Action
BTK
Approved Drug List
1
Commercial Vendor
Beigene